Pharmapack Europe Launches Start-up Hub
The Start-up Hub is designed to give start-up companies the opportunity to network at Pharmapack.
On May 31, 2016 Pharmapack Europe announced the launch of its Start-up Hub, a new addition to the 2017 event at the Paris Expo Porte de Versailles from February 1-2, 2017. According to Pharmapack, the Start-up Hub is a platform designed to give young pharmaceutical firms the ability to network at the conference for an affordable price. Companies at the Start-up Hub will have the opportunity to showcase ideas, meet potential customers, partners and investors, and forge new relationships.
According to Pharmapack, there are only ten spots available for companies in the Start-up Hub. Exhibitors will be selected by Pharmapack’s advisory board of industry experts. The board will fill available spots based on the uniqueness, market prospects, patient impact, and savings potential of each company’s innovations, Pharmapack said in a press announcement. Firms pursuing all types of pharma and biopharma packaging innovation are encouraged to apply. Entry closes on July 28, 2016 and recipients will be announced in early September.
Source: Pharmapack Europe
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
In Wake of Trump Tariffs, Lilly Plans New US Pharmaceutical Manufacturing Sites
February 26th 2025Previous domestic capital expansion commitments since 2020 had been made in Research Triangle Park and Concord, both in North Carolina; Kenosha County, Wisconsin; Lebanon, Indiana; and Lilly’s home city of Indianapolis.
Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase
Published: February 26th 2025 | Updated: February 26th 2025While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of the acquisition.
